Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 36,578,270 | 37,916,180 | 41,475,020 | 41,895,770 | 43,939,700 |
| Cost of Goods | 13,536,240 | 12,069,030 | 13,433,800 | 12,512,770 | 11,763,460 |
| Gross Profit | 23,042,030 | 25,847,150 | 28,041,210 | 29,382,990 | 32,176,240 |
| Operating Expenses | 7,259,930 | 20,429,870 | 17,650,170 | 17,666,700 | 19,651,140 |
| Operating Income | 15,782,340 | 5,417,309 | 10,391,850 | 11,717,070 | 12,525,560 |
| Interest Expense | 1,157,453 | 1,198,160 | 1,200,200 | 1,280,760 | 0 |
| Other Income | 1,469,363 | 672,411 | 1,209,570 | 171,170 | -174,890 |
| Pre-tax Income | 16,094,250 | 4,891,560 | 10,401,220 | 10,607,480 | 12,350,670 |
| Income Tax | 3,293,466 | 225,780 | 1,594,530 | 3,087,770 | 3,593,850 |
| Net Income Continuous | 12,800,790 | 6,905,888 | 8,510,936 | 8,775,114 | 9,038,523 |
| Minority Interests | -76,450 | N/A | N/A | N/A | N/A |
| Net Income | $12,877,240 | $4,665,770 | $8,806,690 | $7,519,710 | $8,756,810 |
| EPS Basic Total Ops | 6.66 | 2.16 | 4.41 | 3.69 | 4.11 |
| EPS Basic Continuous Ops | 6.62 | 3.59 | 4.40 | 4.47 | 4.49 |
| EPS Diluted Total Ops | 6.59 | 2.14 | 4.34 | 3.69 | 4.06 |
| EPS Diluted Continuous Ops | 6.55 | 3.55 | 4.33 | 4.47 | 4.43 |
| EBITDA(a) | $18,274,610 | $8,756,358 | $12,606,040 | $13,436,900 | $15,216,130 |